Funded Healthcare Startups in China
Among the 11 most recent healthcare funding entries in China, disclosed round sizes are highly uneven: Maisheng Medical’s Venture - Series Unknown round on…
Among the 11 most recent healthcare funding entries in China, disclosed round sizes are highly uneven: Maisheng Medical’s Venture - Series Unknown round on 2025-09-29 is disclosed at $211M, while the next disclosed amount shown is PulseCare at $14M (2025-11-07). The $211M figure dwarfs the rest of the disclosed amounts, creating a clear outlier at the high end.
Date coverage clusters tightly in late 2025, spanning 2025-09-08 to 2025-11-21, with multiple entries landing in mid-to-late September (e.g., 2025-09-20 and 2025-09-17). Geography also concentrates around a few repeated cities (Hangzhou appears for Dino Medical Technology on 2025-09-20, and Ganzhicao Technology on 2025-09-17; Shenzhen appears for PulseCare on 2025-11-07 and Huanova on 2025-10-12). Disclosure patterns further shape the picture: only 2 of 11 rows show disclosed amounts ($14M and $211M), while 9 of 11 are undisclosed.
Most recent rounds
11 shownRelated listings
Frequently asked
What stands out most in disclosed round size, and how does it affect comparisons across the list?
The only disclosed amounts shown are PulseCare’s $14M on 2025-11-07 and Maisheng Medical’s $211M on 2025-09-29; the latter dwarfs the former and any other disclosed figures are not provided (most rows are undisclosed).
Where do rounds cluster by date within the 11-row window?
The list spans 2025-09-08 through 2025-11-21, and several rounds concentrate in mid-to-late September: two entries fall on 2025-09-20 (Chinagene Tech and Dino Medical Technology), with another on 2025-09-17 (Ganzhicao Technology).
Are any cities over-represented among these healthcare financings?
Hangzhou and Shenzhen each appear twice: Hangzhou shows Dino Medical Technology (2025-09-20, undisclosed) and Weixin Medical (Hangzhou, 2025-11-01, undisclosed) plus Ganzhicao Technology (Hangzhou, 2025-09-17, undisclosed), while Shenzhen shows PulseCare (2025-11-07, $14M) and Huanova (2025-10-12, undisclosed).
How does stage classification distribute across the list?
Series A appears frequently (Durofi 2025-11-21; PulseCare 2025-11-07; Weixin Medical 2025-11-01; Jiaoying Medical 2025-10-17; Huanova 2025-10-12; Dino Medical Technology 2025-09-20; Yaoshi Medical 2025-09-08), while Series B is also present (Harbin Institute of Technology Peugeot 2025-11-04; Chinagene Tech 2025-09-20) alongside two entries labeled Venture - Series Unknown (Maisheng Medical 2025-09-29 and Ganzhicao Technology 2025-09-17).
Which entries are within the most recent 90 days of the newest row date shown?
Using the newest date shown (2025-11-21), entries in the prior ~90 days include Durofi (2025-11-21), PulseCare (2025-11-07), Harbin Institute of Technology Peugeot (2025-11-04), Weixin Medical (2025-11-01), Jiaoying Medical (2025-10-17), and Huanova (2025-10-12), plus the mid-to-late September entries starting 2025-09-20.
Are there any outliers besides the large $211M round?
The only clearly disclosed high figure is Maisheng Medical’s $211M (2025-09-29). Everything else with a stated amount is $14M for PulseCare (2025-11-07), while the remaining 9 of 11 rows are undisclosed, making disclosure itself a secondary outlier compared with the two disclosed rounds.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.